BioMark Diagnostics Inc.
BUX
Classement en actions
#26616
BioMark Diagnostics Inc. is an oncology specialist, developing advanced... BioMark Diagnostics Inc. is an oncology specialist, developing advanced diagnostic tools for cancer to enable early detection, continuous patient monitoring, and the assessment of initial treatment efficacy. The firm holds a research partnership with the Icahn School of Medicine, collaborating on clinical trials specifically addressing the early identification of lung cancer. Founded in 2014, its corporate headquarters are situated in Richmond, Canada. BioMark Diagnostics Inc. operates as a subsidiary of Biomark Technologies Inc.
Prix de l'action
$0.34495034
Capitalisation boursière
$36.73M
Changement (1 jour)
0.00%
Changement (1 an)
41.11%
Pays
CA
Échange BioMark Diagnostics Inc. (BUX)
Catégorie
Healthcare
Ratio P/B pour BioMark Diagnostics Inc. (BUX)
Ratio P/B au 2026 TTM : 0
Selon les derniers rapports financiers et le cours de l'action de BioMark Diagnostics Inc., le ratio cours/valeur comptable actuel (TTM) est 0. À la fin de 2026, le ratio P/B était de 0.
Historique du ratio P/B pour BioMark Diagnostics Inc. de 2026 à 2026
Ratio P/B à la fin de chaque année
| Année | Ratio P/B | Changez |
|---|---|---|
| Pas assez de données pour les dates fournies. | ||
Ratio P/B pour des entreprises similaires ou concurrentes
| Entreprise | Ratio P/B | Différence de Ratio P/B | Pays |
|---|---|---|---|
| 4.7411 | - |
US
|
|
| 3.0143 | - |
US
|
|
| 31.051 | - |
US
|
|
| - | - |
CN
|
|
| 6.6641 | - |
US
|
